magnifying glass
logo for GenPath Diagnostics

GenPath Diagnostics

New Jersey, United States · 51 Employees

Get Full Access

Who is GenPath Diagnostics

GenPath, a division of BioReference Laboratories, a subsidiary of OPKO Health, offers a unique, specialized and comprehensive test menu to oncologists, pathologists, urologists, hematologists, maternal fetal medicine specialists, and OB/GYNs. GenPath has a reputation for doing things differently. In fact, our vision is more expansive than just solving todays problems. While unparalleled diagnostics remain at our core, our ultimate goal is to help physicians provide better service and to empower patients with the knowledge to better care for themselves.Read More

Headquarters

Headquarters

481 Edward H. Ross Dr, Elmwood Park, New Jersey, 07407, United States
Phone Number

Phone Number

(800) 633-4522
Revenue

Revenue

$10M
GenPath Diagnostics's Social Media
Popular Searches

Genpath

Genpath Inc

GenPath Diagnostics

GenPath Oncology

GenPath Women's Health

SIC Code 80,807
NAICS Code 62,621

Top Competitors of GenPath Diagnostics

GenPath Diagnostics Org Chart

PhonePhoneEmailEmail
Darrell Fassberg
Darrell Fassberg

Vice President, Sales

PhonePhoneEmailEmail
Maryanne Amato
Maryanne Amato

Vice President and General M...

PhonePhoneEmailEmail

PhonePhoneEmailEmail
Illustration of an envelope

GenPath Diagnostics Company Metrics

Company Insights
Employee Growth Rate
Acquisitions & Subsidiaries

Nov 05, 2021

ModeX Therapeutics

Sep 12, 2018

Laboratorio Buena Salud

Jul 31, 2017

Curna

Feb 02, 2016

PrOlor

Sep 16, 2012

FineTech Pharmaceutical

Mar 07, 2012

Inspiro Medical

See More Acquisitions & Subsidiaries

GenPath Diagnostics Tech Stack

Cloudflare CDN

By

Cloudflare

Microsoft Dynamics 365 Business Cen...

By

Microsoft

ADP

By

ADP

Google Workspace (formerly G Suite)

By

Google
See more technologies

GenPath Diagnostics News & Media

OPKO Health's BioReference Laboratories Launches Best-in-Class Next-Generation Sequencing (NGS) Assay

ELMWOOD PARK, N.J., Sept. 1, 2020 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), along with its specialty oncology division, GenPath, today announced the launch of OnkoSight AdvancedTM, a next-generation sequencing (NGS) assay that enables...

BioReference Laboratories Showcases 2019 Growth through the Addition of Cutting Edge Tests, Greater Access to Services, and Optimized Patient Experience

Elmwood Park, NJ, Dec. 19, 2019 (GLOBE NEWSWIRE) -- BioReference Laboratories, Inc., an OPKO Health Company, along with its genetics and genomics laboratory, GeneDx, Inc., and oncology, urology and women’s health division, GenPath Diagnostics, are pleased to provide a 2019 business update, highlighting new tests that lead to faster diagnoses, payer relationships that provide greater access to care, and new tools that empower patients to take responsibility of their health. Work completed by the
Subscribe to GenPath Diagnostics News

Frequently Asked Questions regarding GenPath Diagnostics

See more information about GenPath Diagnostics

Trending Intent Signals iIntent topics are topics that prospects are actively searching for online.

Find out what GenPath Diagnostics is actively searching across the web.

Topic

Signal Score

iSignal Score indicates how big the spike is compared to a company's historical baseline for consuming content.

Cyber Security

100

5 Signals found

Signal Location
Africa
Date
11/29/22
Score
Audience
GenPath Diagnostics Search Intents

Recruiting

86

4 Signals found

Signal Location
Asia
Date
11/29/22
Score
Audience
GenPath Diagnostics Search Intents

Get Full Access

4.4/5 on G2 Crowd